S H Kelkar & Company’s 9MFY22 sales records 21% yoy growth to Rs1,110cr; Stock gains 2%
4 months ago•India Infoline
Buy S H Kelkar & Company, target price Rs 250: HDFC Securities
4 months ago•Economic Times
Solara Active Pharma Sciences Ltd leads losers in ‘A’ group
6 months ago•Business Standard
S H Kelkar & Company Ltd leads gainers in ‘A’ group
6 months ago•Business Standard
Volumes jump at S H Kelkar & Company Ltd counter
6 months ago•Business Standard
S H Kelkar and Co zooms 19% after 10% equity changes hands via block deals
6 months ago•Business Standard
S H Kelkar stock hits upper circuit post block deals
6 months ago•India Infoline
Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa
Current price is less than the intrinsic value